Tacit Therapeutics emerges from stealth with $19M to develop RNA trans-splicing therapies for brain diseases. Read our feature in Endpoints News.
side

Let’s Talk.

Interested in joining our team or learning more about our Splicing-Direct Repair™ technology? Shoot us an email at info@tacittx.com.

Group 23691
Mask Group 11

Contact